DHT related hair loss

try soy isovflavones and green tea extract



http://www.medicalnewstoday.com/articles/68082.php


http://www.mayoclinic.com/health/soy/NS_patient-soy/DSECTION=safety
Figure 3. Involvement of androgens and the androgen receptor in male-pattern baldness. (a) In the nonbalding
scalp, testosterone enters the cell and is reduced to 5α-dihydrotestosterone (DHT) by 5α-reductase.
DHT binds to the androgen receptor, and the complex moves into the nucleus, where transcription control of
androgen-dependent genes occurs. (b) In the balding scalp, the concentration of 5α-reductase is increased,
resulting in the increased production of DHT. Because the concentration of the androgen receptor also appears
to be increased, more complexes are formed between androgen receptors and DHT, augmenting the regulation
of androgen-dependent genes in the nucleus. The androgen-responsive genes that are involved in malepattern
baldness are yet to be identified. Finasteride, a type-II 5α-reductase inhibitor, reduces the production
of DHT by blocking the action of the type II enzyme, thereby slowing the action of the androgen receptor. The
site of action of minoxidil is yet to be determined. Future therapies might involve the prevention of the binding
of DHT to the androgen receptor (fig003jem)